Cargando…

Clinical and analytical performance of the BD Onclarity™ HPV assay for detection of CIN2+ lesions on SurePath samples

BACKGROUND: The novel BD Onclarity(TM) HPV assay (Onclarity) on the BD Viper™ LT system (BD Diagnostics, Sparks, MD), detects E6/E7 DNA from 13 high-risk HPV genotypes and HPV66. We compared the analytical and clinical performance of the Onclarity Assay to that of Hybrid Capture 2 and LINEAR ARRAY u...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ejegod, Ditte Møller, Junge, Jette, Franzmann, Maria, Kirschner, Benny, Bottari, Fabio, Sideri, Mario, Sandri, Maria-Teresa, Bonde, Jesper
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5886872/ https://www.ncbi.nlm.nih.gov/pubmed/29074183 http://dx.doi.org/10.1016/j.pvr.2016.01.003

Ejemplares similares

The BD Onclarity HPV Assay on Samples Collected in SurePath Medium Meets the International Guidelines for Human Papillomavirus Test Requirements for Cervical Screening
por: Ejegod, Ditte, et al.
Publicado: (2016)

Clinical and Analytical Performance of the BD Onclarity HPV Assay with SurePath Screening Samples from the Danish Cervical Screening Program Using the VALGENT Framework
por: Bonde, Jesper Hansen, et al.
Publicado: (2020)

Clinical Validation of the Onclarity Assay After Assay Migration to the High-Throughput COR Instrument Using SurePath Screening Samples From the Danish Cervical Cancer Screening Program
por: Ejegod, Ditte Møller, et al.
Publicado: (2021)

Comparing SurePath, ThinPrep, and conventional cytology as primary test method: SurePath is associated with increased CIN II(+) detection rates
por: Rozemeijer, Kirsten, et al.
Publicado: (2015)

Prevalence of Human Papillomavirus in 5,072 Consecutive Cervical SurePath Samples Evaluated with the Roche Cobas HPV Real-Time PCR Assay
por: Preisler, Sarah, et al.
Publicado: (2013)

Cervical histology after routine ThinPrep or SurePath liquid-based cytology and computer-assisted reading in Denmark
por: Rebolj, Matejka, et al.
Publicado: (2015)

Bayesian analysis of baseline risk of CIN2 and ≥CIN3 by HPV genotype in a European referral cohort
por: Bonde, Jesper, et al.
Publicado: (2019)

Clinical validation of full genotyping CLART® HPV4S assay on SurePath and ThinPrep collected screening samples according to the international guidelines for human papillomavirus test requirements for cervical screening
por: Ejegod, Ditte Møller, et al.
Publicado: (2020)

Immunocytochemical expression of Ki-67/p16 in normal, atypical, and neoplastic cells in urine cytology using BD SurePath™ as preparation method
por: Østbye, Kirsten Margrethe, et al.
Publicado: (2019)

The effect of the small amount of formaldehyde in the SurePath liquid when establishing protocols for immunocytochemistry
por: Bjønness-Jacobsen, Ellen Cathrine, et al.
Publicado: (2016)

Combining Endometrium Sampling Device and SurePath Preparation to Screen for Endometrial Carcinoma: A Validation Study
por: Wen, Jia, et al.
Publicado: (2015)

Detection of cervical precancerous lesions with Aptima HPV assays using SurePath preservative fluid specimens
por: Chernesky, Max, et al.
Publicado: (2017)

Impact of SurePath(®) liquid-based preparation in cytological analysis of peritoneal washing in practice of gynecologic oncology
por: Tyagi, Ruchita, et al.
Publicado: (2017)

Tubercular granulomas in Bronchoalveolar lavage fluid in SurePath liquid-based cytology smears: An enigmatic finding
por: Badyal, Rama Kumari, et al.
Publicado: (2021)

A comparative analysis of conventional and SurePath liquid-based cervicovaginal cytology: A study of 140 cases
por: Sharma, Jyotsna, et al.
Publicado: (2016)

HPV-Testing in Follow-up of Patients Treated for CIN2+ Lesions
por: Mariani, Luciano, et al.
Publicado: (2016)

Collection of the BD SurePath Pap Test with a broom device plus endocervical brush improves disease detection when compared to the broom device alone or the spatula plus endocervical brush combination
por: Davis-Devine, Sharon, et al.
Publicado: (2008)

Diagnostic sensitivity for invasive cervical carcinoma of high risk HPV tests performed on SurePath™ liquid-based pap specimens
por: Nance, Keith V
Publicado: (2013)

Cytological Evaluation and REBA HPV-ID HPV Testing of Newly Developed Liquid-Based Cytology, EASYPREP: Comparison with SurePath
por: Lee, Youn Soo, et al.
Publicado: (2013)

A comparison of different human papillomavirus tests in PreservCyt versus SurePath in a referral population—PREDICTORS 4
por: Cuzick, Jack, et al.
Publicado: (2016)

Can an inadequate cervical cytology sample in ThinPrep be converted to a satisfactory sample by processing it with a SurePath preparation?
por: Sørbye, Sveinung Wergeland, et al.
Publicado: (2017)

Detection of high-risk HPV in FFPE specimens of various tumours using the BD Onclarity™ HPV Assay
por: van der Geize, Robert, et al.
Publicado: (2022)

Should LSIL with ASC-H (LSIL-H) in cervical smears be an independent category? A study on SurePath™ specimens with review of literature
por: Shidham, Vinod B, et al.
Publicado: (2007)

Additional collection devices used in conjunction with the SurePath Liquid-Based Pap Test broom device do not enhance diagnostic utility
por: Day, Sarah J, et al.
Publicado: (2004)

APTIMA assay on SurePath liquid-based cervical samples compared to endocervical swab samples facilitated by a real time database
por: Khader, Samer N., et al.
Publicado: (2010)

Evaluation of BD Onclarity™ HPV Assay on Self-Collected Vaginal and First-Void Urine Samples as Compared to Clinician-Collected Cervical Samples: A Pilot Study
por: Martinelli, Marianna, et al.
Publicado: (2022)

Unsatisfactory rates vary between cervical cytology samples prepared using ThinPrep and SurePath platforms: a review and meta-analysis
por: Fontaine, Daniel, et al.
Publicado: (2012)

Comparison of Seegene Anyplex II HPV28 assay with BD Onclarity HPV assay for human papillomavirus genotyping
por: Kim, Moonsik, et al.
Publicado: (2022)

Evaluation of the Performance of CinTec® PLUS in SurePathTM Liquid-Based Cervico-Vaginal Samples
por: Sharma, Pooja, et al.
Publicado: (2021)

Diagnostic Utility and Efficacy of Conventional Versus SurePath® Liquid-based Cytology in Head and Neck Pathology: A Study in an Indian Tertiary Care Hospital
por: Sharma, Sonam, et al.
Publicado: (2018)

Cervical cancer incidence after normal cytological sample in routine screening using SurePath, ThinPrep, and conventional cytology: population based study
por: Rozemeijer, Kirsten, et al.
Publicado: (2017)

Human Papillomavirus Same Genotype Persistence and Risk: A Systematic Review
por: Bonde, Jesper, et al.
Publicado: (2020)

Comparison of analytical and clinical performance of CLART HPV2 genotyping assay to Linear Array and Hybrid Capture 2: a split-sample study
por: Ejegod, Ditte Møller, et al.
Publicado: (2015)

A prospective randomized noninferiority trial comparing conventional smears and SurePath(TM) liquid-based cytology in endoscopic ultrasound-guided sampling of esophageal, gastric, and duodenal lesions
por: Jun, Jae Chang, et al.
Publicado: (2023)

Evaluation of the characteristics of multiple human papillomavirus (HPV) infections identified using the BD Onclarity HPV assay and comparison with those of single HPV infection
por: Kim, Jinhee, et al.
Publicado: (2022)

Comparison of the Cepheid Xpert HPV test and the HC2 High-Risk HPV DNA Test for detection of high-risk HPV infection in cervical smear samples in SurePath preservative fluid
por: Rabaan, Ali A., et al.
Publicado: (2018)

Human Papillomavirus Assays and Cytology in Primary Cervical Screening of Women Aged 30 Years and Above
por: Rebolj, Matejka, et al.
Publicado: (2016)

Differential Detection of Human Papillomavirus Genotypes and Cervical Intraepithelial Neoplasia by Four Commercial Assays
por: Rebolj, Matejka, et al.
Publicado: (2016)

Time and temperature dependent analytical stability of dry-collected Evalyn HPV self-sampling brush for cervical cancer screening
por: Ejegod, Ditte Møller, et al.
Publicado: (2018)

HPV prevalence and genotype distribution in a population-based split-sample study of well-screened women using CLART HPV2 Human Papillomavirus genotype microarray system
por: Bonde, Jesper, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_bp4vedfdom7l7275luhv7qe6q9